AMERICAN THORACIC SOCIETY IMAGE: FEVER FOUND TO BE THE MOST COMMON NON-RESPIRATORY FEATURE OF COVID-19 INFECTION. CREDIT: ATS Session: C58, Health Services Research in Diverse SettingsDate and Time: 11:30 a.m. ET, Tuesday, May 23, 2023Location: WEWCC, Area 1, Hall C (Lower Level) ATS 2023, Washington, DC – Fever was found to be the most common non-respiratory feature of infection...
By Tarun Sai Lomte Feb 13 2023Reviewed by Aimee Molineux In a recent study posted to medRxiv* preprint server, researchers examined the factors associated with stroke following coronavirus disease 2019 (COVID-19) vaccination. Study: Factors Associated with Stroke after COVID-19 Vaccination: A Statewide Analysis. Image Credit: BaLL LunLa/Shutterstock Background Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...
Reviewed by Emily Henderson, B.Sc. Nov 16 2022 COVID-19 reactivated viruses that had become latent in cells following previous infections, particularly in people with chronic fatigue syndrome, also known as ME/CFS. This is the conclusion of a study from Linköping University in Sweden. The results, published in Frontiers in Immunology, contribute to our knowledge of the...
OSAKA UNIVERSITY IMAGE: THE INSULIN/IGF SIGNALING PATHWAY PLAYS AN IMPORTANT ROLE IN MANY BIOLOGICAL PROCESSES, SUCH AS ENERGY METABOLISM AND CELL SURVIVAL. SARS-COV-2 INFECTION IMPAIRS TRANSCRIPTIONAL EXPRESSION OF THE INSULIN/IGF SIGNALING PATHWAY IN THE HOST LUNG, LIVER ADIPOSE TISSUE, AND PANCREATIC CELLS, WHICH IS LIKELY ATTRIBUTED TO INTERFERON REGULATORY FACTOR 1 (IRF1). THE PATHOLOGICAL TRAIT...
INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE – INRS IMAGE: PROFESSOR CHARLES RAMASSAMY AND HIS POSTDOCTORAL RESEARCHER MOHAMED HADDAD WHO CONDUCTED THE RESEARCH AT INRS. CREDIT: INRS Professor Charles Ramassamy and his postdoctoral researcher Mohamed Haddad at Institut national de la recherche scientifique (INRS), in collaboration with scientists from Université de Montréal, McGill University, and Université du Québec à Montréal...
By Jocelyn Solis-Moreira Oct 31 2021 Research published in the journal Nature Medicine suggests a risk for neurological complications after the first shot of a COVID-19 vaccine. However, the likelihood of developing neurological complications remains far greater among people infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Study: Neurological complications after first dose of COVID-19 vaccines...
By Sally Robertson, B.Sc. Sep 27 2021 Researchers in the UK and Germany have provided evidence for a novel mechanism by which severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – binds to human host cells. The team – from the Wellcome Sanger Institute in Cambridge, the...
by University of Birmingham Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: National Institute of Allergy and Infectious Diseases, NIH A licensed drug normally used to treat abnormal levels of fatty substances in the blood could...
By Dr. Tomislav Meštrović, MD, Ph.D. Jul 7 2021 A recent study by researchers from the United Kingdom (UK) revealed that antibody levels associated with protection against reinfection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are likely to last from 1.5 to 2 years on average and that the protection from severe infection...
IMPERIAL COLLEGE LONDON A single dose of vaccine boosts protection against SARS-CoV-2 coronavirus variants, but only in those with previous COVID-19, a study has found. In those who have not previously been infected and have so far only received one dose of vaccine the immune response to variants of concern may be insufficient. The findings,...
